Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 439 KiB)
Schmitt, M.; Silva, M.; Konukiewitz, B.; Lang, C.; Steiger, K.; Halfter, K.; Engel, J.; Jank, P.; Pfarr, N.; Wilhelm, D.; Foersch, S.; Denkert, C.; Tschurtschenthaler, M.; Weichert, W.; Jesinghaus, M. Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups. Cancers 2021, 13, 6177. https://doi.org/10.3390/cancers13246177
Schmitt M, Silva M, Konukiewitz B, Lang C, Steiger K, Halfter K, Engel J, Jank P, Pfarr N, Wilhelm D, Foersch S, Denkert C, Tschurtschenthaler M, Weichert W, Jesinghaus M. Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups. Cancers. 2021; 13(24):6177. https://doi.org/10.3390/cancers13246177
Chicago/Turabian StyleSchmitt, Maxime, Miguel Silva, Björn Konukiewitz, Corinna Lang, Katja Steiger, Kathrin Halfter, Jutta Engel, Paul Jank, Nicole Pfarr, Dirk Wilhelm, Sebastian Foersch, Carsten Denkert, Markus Tschurtschenthaler, Wilko Weichert, and Moritz Jesinghaus. 2021. "Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups" Cancers 13, no. 24: 6177. https://doi.org/10.3390/cancers13246177